Response to induction chemotherapy modifies the effect of conventional prognostic factors in high-risk neuroblastoma: A report from the Children’s Oncology Group
The impact of conventional prognostic factors is not static in patients with HR-NB. Instead, response to induction chemotherapy modifies the effect of conventional prognostic factors. These data can help to further refine prognosis for patients with variable responses to induction and help to identify candidates who might benefit from treatment other than standard post-induction therapy.
Authors
- Arlene Naranjo (ORCID: https://orcid.org/0000-0001-7737-4324)
- Steven G. DuBois (ORCID: https://orcid.org/0000-0003-0882-738X)
- Elizabeth Sokol (ORCID: https://orcid.org/0000-0002-1787-6901)
- Julie R. Park (ORCID: https://orcid.org/0000-0002-6777-9165)
- Susan G. Kreissman (ORCID: https://orcid.org/0000-0003-3732-4394)
- Rochelle Bagatell (ORCID: https://orcid.org/0000-0002-5729-8819)
- M. Meaghan Granger
- Brian LaBarre (ORCID: https://orcid.org/0009-0001-6566-6861)
- Navin Pinto (ORCID: https://orcid.org/0000-0002-8775-6710)
Institutions
- St. Jude Children's Research Hospital (US)
- Children's Hospital of Philadelphia (US)
- Harvard University (US)
- University of Florida (US)
- Children's Hospital Colorado (US)
- Lurie Children's Hospital (US)
- Duke Medical Center (US)
- Children's Oncology Group (US)
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- University of Pennsylvania (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- EJC Paediatric Oncology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.ejcped.2024.100193
- Citations
- 2
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- St. Baldrick's Foundation
- National Cancer Institute